(1) The UK-headquartered bioelectronics company has set its sights on the US healthtech market following a series of new investors, new product developments and a 156% sales increase. Leading bioelectronic innovator NuroKor BioElectronics has announced plans to ramp up its US expansion, following 12 months of rapid growth during which the company's half-year sales rose by 156%. NuroKor, which pioneers the development of wearable technology that uses bioelectric nerve, muscle and microcurrent stimulation to help manage pain and optimise physical performance, has today announced a major new par...